| Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis H Shafqat, S Ali, M Salhab, AJ Olszewski Diseases of the Colon & Rectum 58 (3), 294-303, 2015 | 114 | 2015 |
| Adjuvant therapy for resected gallbladder cancer: analysis of the national cancer data base KC Mantripragada, F Hamid, H Shafqat, AJ Olszewski Journal of the National Cancer Institute 109 (2), djw202, 2017 | 71 | 2017 |
| Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy H Shafqat, T Gourdin, A Sion Seminars in Oncology 45 (3), 156-163, 2018 | 67 | 2018 |
| Hypertriglyceridemia-induced pancreatitis: a decade of experience in a community-based teaching hospital ME Afari, H Shafqat, M Shafi, FY Marmoush, MB Roberts, T Minami RI Med J 98 (12), 40-3, 2015 | 22 | 2015 |
| Disparate survival outcomes after front-line chemoimmunotherapy in older patients with follicular, nodal marginal zone and small lymphocytic lymphoma AJ Olszewski, H Shafqat, S Ali Leukemia & Lymphoma 56 (4), 942-950, 2015 | 15 | 2015 |
| Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia A Chorzalska, I Salloum, H Shafqat, S Khan, P Marjon, D Treaba, ... Leukemia 28 (11), 2165-2177, 2014 | 15 | 2014 |
| Severe hypocalcemia after denosumab in a patient with acquired Fanconi syndrome H Shafqat, KF Alquadan, AJ Olszewski Osteoporosis International 25, 1187-1190, 2014 | 12 | 2014 |
| PREDICTIVE ACCURACY OF MODEL FOR END STAGE LIVER DISEASE (MELD) AS A PROGNOSTIC MARKER FOR CIRRHOSIS IN COMPARISON WITH CHILD–PUGH SCORE: Child–Pugh Classification Vs MELD UB Zubair, A Salamat, MM Alam, H Shafqat, F Saeed Pakistan Armed Forces Medical Journal 65 (1), 22-25, 2015 | 5 | 2015 |
| Assessment of patients with chronic liver disease qualifying for liver transplant A Salamat, UB Zubair, H Shafqat, F Saeed Pakistan Armed Forces Medical Journal 62 (1), 3-6, 2012 | 5 | 2012 |
| Chlorambucil-induced acute interstitial pneumonitis H Shafqat, AJ Olszewski Case reports in hematology 2014, 2014 | 4 | 2014 |
| Association of immune related adverse events with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy irrespective of corticosteroid use. H Shafqat, TS Gourdin, AM Sion Journal of Clinical Oncology 36 (15_suppl), e15088-e15088, 2018 | 1 | 2018 |
| Comparison of Frequency of Sore Throat and Cough after Prophylactic Lignocaine and Beclomethasone in Adults A Ali, N Ahmed, H Shafqat, A Hussain, M Sultan, M Akram Pakistan Armed Forces Medical Journal 72 (5), 1585-88, 2022 | | 2022 |
| Outcomes of multimodality therapy for gallbladder cancer in the United States (US): Analysis of the National Cancer Data Base (NCDB). F Hamid, H Shafqat, K Mantripragada, T Guerrero, P Somasundar, ... Journal of Clinical Oncology 34 (4_suppl), 313-313, 2016 | | 2016 |
| Survival of high-grade neuroendocrine carcinomas (HGNEC) of the colon and rectum: Analysis of the Surveillance, Epidemiology, and End Results (SEER) database. H Shafqat, S Ali, M Salhab, AJ Olszewski Journal of Clinical Oncology 32 (15_suppl), 3541-3541, 2014 | | 2014 |
| Survival After Rituximab-Based Chemoimmunotherapy In Older Patients With Follicular, Nodal Marginal Zone and Small Lymphocytic Lymphoma: Analysis Of SEER-Medicare Data AJ Olszewski, S Ali, H Shafqat Blood 122 (21), 1736, 2013 | | 2013 |
| Abstract LB-350: Abelson interactor-1 (Abi1) expression levels as a prognostic and drug resistance marker in Bcr-Abl positive leukemias. AD Chorzalska, I Salloum, H Shafqat, S Khan, P Marjon, V Falanga, ... Cancer Research 73 (8_Supplement), LB-350-LB-350, 2013 | | 2013 |
| Case Report Chlorambucil-Induced Acute Interstitial Pneumonitis H Shafqat, AJ Olszewski | | |
